BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 31692039)

  • 21. p16INK4A mediates cyclin dependent kinase 4 and 6 inhibition in senescent prostatic epithelial cells.
    Sandhu C; Peehl DM; Slingerland J
    Cancer Res; 2000 May; 60(10):2616-22. PubMed ID: 10825132
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma.
    Easton J; Wei T; Lahti JM; Kidd VJ
    Cancer Res; 1998 Jun; 58(12):2624-32. PubMed ID: 9635589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glutaredoxin-1 Silencing Induces Cell Senescence via p53/p21/p16 Signaling Axis.
    Yang F; Yi M; Liu Y; Wang Q; Hu Y; Deng H
    J Proteome Res; 2018 Mar; 17(3):1091-1100. PubMed ID: 29356545
    [TBL] [Abstract][Full Text] [Related]  

  • 24. p16(INK4a) protects against dysfunctional telomere-induced ATR-dependent DNA damage responses.
    Wang Y; Sharpless N; Chang S
    J Clin Invest; 2013 Oct; 123(10):4489-501. PubMed ID: 24091330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. γ-Tocotrienol prevents cell cycle arrest in aged human fibroblast cells through p16
    Zainuddin A; Chua KH; Tan JK; Jaafar F; Makpol S
    J Physiol Biochem; 2017 Feb; 73(1):59-65. PubMed ID: 27743340
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guilu Erxian Glue () Inhibits Chemotherapy-Induced Bone Marrow Hematopoietic Stem Cell Senescence in Mice May via p16
    Wang J; Ying YY; Chen ZH; Shao KD; Zhang WP; Lin SY
    Chin J Integr Med; 2020 Nov; 26(11):819-824. PubMed ID: 32915425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recovery of function in osteoarthritic chondrocytes induced by p16INK4a-specific siRNA in vitro.
    Zhou HW; Lou SQ; Zhang K
    Rheumatology (Oxford); 2004 May; 43(5):555-68. PubMed ID: 15026580
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of HSP90, CDC37, and CRM1 as modulators of P16(INK4A) activity in rat liver carcinogenesis and human liver cancer.
    Pascale RM; Simile MM; Calvisi DF; Frau M; Muroni MR; Seddaiu MA; Daino L; Muntoni MD; De Miglio MR; Thorgeirsson SS; Feo F
    Hepatology; 2005 Dec; 42(6):1310-9. PubMed ID: 16317707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The physiology of p16(INK4A)-mediated G1 proliferative arrest.
    Shapiro GI; Edwards CD; Rollins BJ
    Cell Biochem Biophys; 2000; 33(2):189-97. PubMed ID: 11325039
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two mechanisms underlying the loss of p16(Ink4a) function are associated with distinct tumorigenic consequences for WS MEFs escaping from senescence.
    Wu X; Jia S; Zhang X; Si X; Tang W; Luo Y
    Mech Ageing Dev; 2012 Aug; 133(8):549-55. PubMed ID: 22813853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intrinsic cooperation between p16INK4a and p21Waf1/Cip1 in the onset of cellular senescence and tumor suppression in vivo.
    Takeuchi S; Takahashi A; Motoi N; Yoshimoto S; Tajima T; Yamakoshi K; Hirao A; Yanagi S; Fukami K; Ishikawa Y; Sone S; Hara E; Ohtani N
    Cancer Res; 2010 Nov; 70(22):9381-90. PubMed ID: 21062974
    [TBL] [Abstract][Full Text] [Related]  

  • 32. p16
    Al-Khalaf HH; Aboussekhra A
    Mol Carcinog; 2017 Mar; 56(3):985-999. PubMed ID: 27596953
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A two-stage, p16(INK4A)- and p53-dependent keratinocyte senescence mechanism that limits replicative potential independent of telomere status.
    Rheinwald JG; Hahn WC; Ramsey MR; Wu JY; Guo Z; Tsao H; De Luca M; Catricalà C; O'Toole KM
    Mol Cell Biol; 2002 Jul; 22(14):5157-72. PubMed ID: 12077343
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protection against chemotherapy-induced cytotoxicity by cyclin-dependent kinase inhibitors (CKI) in CKI-responsive cells compared with CKI-unresponsive cells.
    Schmidt M; Fan Z
    Oncogene; 2001 Sep; 20(43):6164-71. PubMed ID: 11593424
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1,25-Dihydroxyvitamin D exerts an antiaging role by activation of Nrf2-antioxidant signaling and inactivation of p16/p53-senescence signaling.
    Chen L; Yang R; Qiao W; Zhang W; Chen J; Mao L; Goltzman D; Miao D
    Aging Cell; 2019 Jun; 18(3):e12951. PubMed ID: 30907059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. S-phase lengthening induced by p16(INK4a) overexpression in malignant cells with wild-type pRb and p53.
    Chien WW; Domenech C; Catallo R; Salles G; Ffrench M
    Cell Cycle; 2010 Aug; 9(16):3286-96. PubMed ID: 20703084
    [TBL] [Abstract][Full Text] [Related]  

  • 37. H3K9me-enhanced DNA hypermethylation of the p16INK4a gene: an epigenetic signature for spontaneous transformation of rat mesenchymal stem cells.
    Zheng Y; He L; Wan Y; Song J
    Stem Cells Dev; 2013 Jan; 22(2):256-67. PubMed ID: 22873822
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knockdown of AGR2 induces cellular senescence in prostate cancer cells.
    Hu Z; Gu Y; Han B; Zhang J; Li Z; Tian K; Young CY; Yuan H
    Carcinogenesis; 2012 Jun; 33(6):1178-86. PubMed ID: 22467239
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Molecular mechanisms controlling the cell cycle: fundamental aspects and implications for oncology].
    Viallard JF; Lacombe F; Belloc F; Pellegrin JL; Reiffers J
    Cancer Radiother; 2001 Apr; 5(2):109-29. PubMed ID: 11355576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of ginsenoside Rg1 on the senescence of vascular smooth muscle cells.
    Li SG; Yan MZ; Zhang D; Ye M; Deng JJ
    Genet Mol Res; 2016 Sep; 15(3):. PubMed ID: 27706682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.